APA (7th ed.) Citation

WS, C., HC, H., TM, L., YS, C., YC, L., TT, K., . . . CC, C. (2025). Hydroxychloroquine dose-dependently reduces the risk of incident diabetes in primary Sjögren syndrome patients on glucocorticoids: A nationwide population-based cohort study. Arthritis research & therapy, 27(1), 88. https://doi.org/10.1186/s13075-025-03542-7

Chicago Style (17th ed.) Citation

WS, Chen, et al. "Hydroxychloroquine Dose-dependently Reduces the Risk of Incident Diabetes in Primary Sjögren Syndrome Patients on Glucocorticoids: A Nationwide Population-based Cohort Study." Arthritis Research & Therapy 27, no. 1 (2025): 88. https://doi.org/10.1186/s13075-025-03542-7.

MLA (9th ed.) Citation

WS, Chen, et al. "Hydroxychloroquine Dose-dependently Reduces the Risk of Incident Diabetes in Primary Sjögren Syndrome Patients on Glucocorticoids: A Nationwide Population-based Cohort Study." Arthritis Research & Therapy, vol. 27, no. 1, 2025, p. 88, https://doi.org/10.1186/s13075-025-03542-7.